How cognitive evaluations can aid in meeting the growing demand for more comprehensive safety profiles.
Kenton Zavitz, PhD
Advertisement
Director, Clinical Affairs, Cambridge Cognition
Articles by Kenton Zavitz, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Accelerating Site Payments with Agentic AI: See it in Action
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
